- A Case of Adult-onset Urticaria Pigmentosa with Bone Involvement
-
Park J, Yoo KH, Han TY, Li K, Seo SJ, Hong CK
- KMID: 2247772
- Korean J Dermatol.
- 2009 Sep;47(9):1060-1062.
Urticaria pigmentosa (UP) is the most common variant of cutaneous mastocytosis. Primarily a disease of childhood, in over one-half of the cases onset is before 2 years of age, and... -
- CITED
-
- Close
- SHARE
-
- Close
- Solitary mastocytoma presenting at birth
-
Ha NH, Lee YJ, Park MC, Lee IJ, Kim SM, Park DH
- KMID: 2417796
- Arch Craniofac Surg.
- 2018 Jun;19(2):127-130.
- doi: 10.7181/acfs.2018.01508
Mastocytosis is a rare disease which occurs in both children and adults, and it can manifest as a solitary or multiple skin lesions. Both can cause cutaneous or systemic symptoms.... -
- CITED
-
- Close
- SHARE
-
- Close
- Successful Remission of Recurrent Anaphylaxis after Omalizumab Administration in a Patient with Systemic Mastocytosis
-
Moon H, Jang HJ, Lee CG, Kim YC, Yoo SH, Lee DS, Kang HR
- KMID: 2435039
- Korean J Med.
- 2018 Feb;93(1):68-73.
- doi: 10.3904/kjm.2018.93.1.68
Mastocytosis is a disorder characterized by abnormal mast cell proliferation and accumulation in one or more tissues. It presents in two major variants: cutaneous mastocytosis and systemic mastocytosis. Because the... -
- CITED
-
- Close
- SHARE
-
- Close
- Massive splenomegaly: flow cytometry as a diagnostic tool for systemic mastocytosis
-
Rastogi L, Dass J, Dhingra G, Gupta N, Kotwal J
- KMID: 2429327
- Blood Res.
- 2018 Sep;53(3):251-254.
- doi: 10.5045/br.2018.53.3.251
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- A case of lymphocytic variant hypereosinophilic syndrome with sub-diagnostic systemic mastocytosis
-
Jain P, Wang SA, Yin CC, Abaza Y, Verstovsek S, Estrov Z
- KMID: 2375210
- Blood Res.
- 2017 Mar;52(1):71-73.
- doi: 10.5045/br.2017.52.1.71
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Aggressive Systemic Mastocytosis Following Ovarian Germ Cell Tumor
-
Huh EJ, Park SY, Choi SR, Chung SY, Kang JH, Kim KM, Lee JH, Jeong DC
- KMID: 2252350
- Korean J Hematol.
- 2005 Jun;40(2):129-133.
- doi: 10.5045/kjh.2005.40.2.129
A 4 years-old girl was diagnosed with aggressive systemic mastocytosis at 2 months after the end of chemotherapy including cisplatin, bleomycin and etoposide for an ovarian germ cell tumor (GCT).... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case Report of Systemic Mastocytosis
-
Chung KT, Koo J, Moon SK
- KMID: 1946139
- J Korean Pediatr Soc.
- 1979 Jul;22(7):546-549.
A case of systemic mastocytosis in a 6 year old boy was presented. Skin lesions started to appear and spred several days after birth along with severe itching sensation, and... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Systemic Mastocytosis Associated with Acute Myeloid Leukemia Terminating as Aleukemic Mast Cell Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation
-
Bae MH, Kim HK, Park CJ, Seo EJ, Park SH, Cho YU, Jang S, Chi HS, Lee KH
- KMID: 1781312
- Ann Lab Med.
- 2013 Mar;33(2):125-129.
- doi: 10.3343/alm.2013.33.2.125
In up to 40% of systemic mastocytosis (SM) cases, an associated clonal hematological non-mast cell lineage disease such as AML is diagnosed before, simultaneously with, or after the diagnosis of... -
- CITED
-
- Close
- SHARE
-
- Close
- Favorable outcome of omalizumab treatment in a patient with idiopathic anaphylaxis
-
Ban GY, Yang EM, Kim JH, Shin YS, Ye YM, Nahm DH, Park HS
- KMID: 2218651
- Allergy Asthma Respir Dis.
- 2015 Sep;3(5):380-383.
- doi: 10.4168/aard.2015.3.5.380
Anaphylaxis is a severe and life-threatening systemic reaction. Despite the extensive evaluation to determine the cause, 30%-60% of cases of anaphylaxis in adults remain idiopathic. Recently, omalizumab treatment has been... -
- CITED
-
- Close
- SHARE
-
- Close
- A scientific treatment approach for acute mast cell leukemia: using a strategy based on next-generation sequencing data
-
Youk J, Koh Y, Kim JW, Kim DY, Park H, Jung WJ, Ahn KS, Yun H, Park I, Sun CH, Lee S, Yoon SS
- KMID: 2172740
- Blood Res.
- 2016 Mar;51(1):17-22.
- doi: 10.5045/br.2016.51.1.17
BACKGROUND: Mast cell leukemia (MCL) is the most aggressive form of systemic mastocytosis disorders. Owing to its rarity, neither pathogenesis nor standard treatment is established for this orphan disease. Hence,... -
- CITED
-
- Close
- SHARE
-
- Close
